{"title":"Influenza vaccination coverage rates and other related factors in high-risk groups in Birjand, East of Iran.","authors":"Azadeh Ebrahimzadeh, Bita Bijari, Amin Azarnoosh, Fatemeh Shakhs Emampour","doi":"10.1177/25151355221140229","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and aims: </strong>Influenza is an acute respiratory disease with the highest mortality rate in the high-risk groups. Vaccination is a key public health strategy to prevent influenza in high-risk people. This study aimed to assess the influenza vaccination coverage rate and identify its demographic determinants in patients with end-stage renal disease (ESRD), chronic obstructive pulmonary disease (COPD), and diabetes in Birjand, Eastern Iran.</p><p><strong>Methods: </strong>This cross-sectional study included 400 patients (300 diabetic, 60 dialysis, and 40 COPD patients) from September 2017 to August 2018. Using interview method, we completed a questionnaire containing the patients' demographic characteristics, questions about patients' knowledge and attitude toward influenza vaccination, the influenza vaccination history, and the most common causes for vaccination. The relationship between the type of disease and patients' characteristics (exposure) with vaccination coverage (outcome) was investigated.</p><p><strong>Results: </strong>The mean age of participants was 58.7 ± 11.3 years. Also, 58.8% of the patients received at least one dose of the vaccine and the regular injection rate was 32.8%. The coverage of influenza vaccine in dialysis patients was significantly higher than other patients (<i>p</i> < 0.001). The mean knowledge score was 6.17 ± 2.15 out of maximum 9 scores. There was a positive association between age [<i>p</i> = 0.001, odds ratio (OR) = 1.04] and patients' knowledge (<i>p</i> < 0.001, OR = 1.42) with the vaccination coverage.</p><p><strong>Conclusion: </strong>The coverage of influenza vaccine in high-risk patients in Birjand was low. Hence, it is essential to increase the knowledge of high-risk groups about the importance of influenza vaccination and facilitate their access to vaccines.</p>","PeriodicalId":33285,"journal":{"name":"Therapeutic Advances in Vaccines and Immunotherapy","volume":" ","pages":"25151355221140229"},"PeriodicalIF":0.0000,"publicationDate":"2022-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/65/2c/10.1177_25151355221140229.PMC9703479.pdf","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Vaccines and Immunotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/25151355221140229","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 2
Abstract
Background and aims: Influenza is an acute respiratory disease with the highest mortality rate in the high-risk groups. Vaccination is a key public health strategy to prevent influenza in high-risk people. This study aimed to assess the influenza vaccination coverage rate and identify its demographic determinants in patients with end-stage renal disease (ESRD), chronic obstructive pulmonary disease (COPD), and diabetes in Birjand, Eastern Iran.
Methods: This cross-sectional study included 400 patients (300 diabetic, 60 dialysis, and 40 COPD patients) from September 2017 to August 2018. Using interview method, we completed a questionnaire containing the patients' demographic characteristics, questions about patients' knowledge and attitude toward influenza vaccination, the influenza vaccination history, and the most common causes for vaccination. The relationship between the type of disease and patients' characteristics (exposure) with vaccination coverage (outcome) was investigated.
Results: The mean age of participants was 58.7 ± 11.3 years. Also, 58.8% of the patients received at least one dose of the vaccine and the regular injection rate was 32.8%. The coverage of influenza vaccine in dialysis patients was significantly higher than other patients (p < 0.001). The mean knowledge score was 6.17 ± 2.15 out of maximum 9 scores. There was a positive association between age [p = 0.001, odds ratio (OR) = 1.04] and patients' knowledge (p < 0.001, OR = 1.42) with the vaccination coverage.
Conclusion: The coverage of influenza vaccine in high-risk patients in Birjand was low. Hence, it is essential to increase the knowledge of high-risk groups about the importance of influenza vaccination and facilitate their access to vaccines.
背景和目的:流感是高危人群中死亡率最高的一种急性呼吸道疾病。疫苗接种是在高危人群中预防流感的一项关键公共卫生战略。本研究旨在评估伊朗东部Birjand地区终末期肾病(ESRD)、慢性阻塞性肺疾病(COPD)和糖尿病患者的流感疫苗接种覆盖率,并确定其人口统计学决定因素。方法:本横断面研究纳入了2017年9月至2018年8月的400例患者(300例糖尿病患者,60例透析患者和40例COPD患者)。采用访谈法,对患者的人口学特征、对流感疫苗接种的知识和态度、流感疫苗接种史、最常见的疫苗接种原因进行问卷调查。调查了疾病类型和患者特征(暴露)与疫苗接种覆盖率(结果)之间的关系。结果:参与者平均年龄58.7±11.3岁。此外,58.8%的患者至少接种了一剂疫苗,常规注射率为32.8%。透析患者流感疫苗接种率显著高于其他患者(p p = 0.001,优势比(OR) = 1.04),且患者对流感疫苗的了解程度显著高于其他患者(p p = 0.001, OR = 1.04)。因此,必须提高高危人群对流感疫苗接种重要性的认识,并便利他们获得疫苗。